{"id":"placebo-g-csf","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Bone pain"},{"rate":"10-20%","effect":"Fatigue"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Injection site reaction"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Muscle pain"},{"rate":"5-10%","effect":"Rash"},{"rate":"1-5%","effect":"Thrombocytopenia"},{"rate":"1-5%","effect":"Anemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"G-CSF works by binding to its receptor on the surface of bone marrow cells, triggering a signaling cascade that leads to increased production of neutrophils. This can help to boost the immune system and fight off infections.","oneSentence":"G-CSF stimulates the bone marrow to produce more neutrophils, a type of white blood cell.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:51:28.023Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Neutropenia"}]},"trialDetails":[{"nctId":"NCT05029141","phase":"PHASE2","title":"New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2021-09-01","conditions":"Acute Myeloid Leukemia, Refractory Acute Leukemia, Relapsed Adult AML","enrollment":21},{"nctId":"NCT06059391","phase":"PHASE2","title":"CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-07-12","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia","enrollment":216},{"nctId":"NCT05421416","phase":"PHASE2","title":"Loratadine for the Prevention of G-CSF-related Bone Pain","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2024-11-28","conditions":"Stem Cell Transplant Complications","enrollment":78},{"nctId":"NCT03246529","phase":"PHASE3","title":"A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioLineRx, Ltd.","startDate":"2018-03-23","conditions":"Multiple Myeloma","enrollment":180},{"nctId":"NCT02739295","phase":"PHASE4","title":"G-CSF in the Treatment of Toxic Epidermal Necrolysis","status":"COMPLETED","sponsor":"University of Liege","startDate":"2016-07","conditions":"Stevens - Johnson Syndrome","enrollment":10},{"nctId":"NCT06514508","phase":"PHASE3","title":"Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients","status":"RECRUITING","sponsor":"Guangzhou Gloria Biosciences Co., Ltd.","startDate":"2025-12-01","conditions":"Multiple Myeloma","enrollment":60},{"nctId":"NCT01933932","phase":"PHASE3","title":"Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2013-09-25","conditions":"Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV","enrollment":510},{"nctId":"NCT03036488","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-03-07","conditions":"Triple Negative Breast Neoplasms","enrollment":1174},{"nctId":"NCT03945812","phase":"PHASE4","title":"Platelet-Rich Plasma vs. Granulocyte Colony-Stimulating Factor vs. Placebo and Outcomes in Frozen Embryo Transfer","status":"COMPLETED","sponsor":"Wael Elbanna Clinic","startDate":"2019-06-01","conditions":"Infertility, Frozen Embryo Transfer (FET)","enrollment":665},{"nctId":"NCT06890039","phase":"PHASE2","title":"A-TANGO Phase 2 Study","status":"NOT_YET_RECRUITING","sponsor":"Yaqrit Ltd","startDate":"2025-09-01","conditions":"Acute-On-Chronic Liver Failure, Alcoholic Hepatitis, Liver Cirrhosis, Alcoholic","enrollment":78},{"nctId":"NCT04447469","phase":"PHASE2, PHASE3","title":"Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation","status":"COMPLETED","sponsor":"Kiniksa Pharmaceuticals International, plc","startDate":"2020-07-28","conditions":"COVID","enrollment":814},{"nctId":"NCT01566695","phase":"PHASE3","title":"The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)","status":"COMPLETED","sponsor":"Celgene","startDate":"2013-04-26","conditions":"Myelodysplastic Syndrome","enrollment":216},{"nctId":"NCT06265077","phase":"PHASE1, PHASE2","title":"Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients","status":"COMPLETED","sponsor":"Noha Mansour","startDate":"2024-02-01","conditions":"Breast Cancer, Filgrastim Adverse Reaction","enrollment":58},{"nctId":"NCT04998279","phase":"","title":"Intrauterine Infusion of GCSF and Reproductive Outcomes in Infertile Women with History of RIF","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-09-01","conditions":"Recurrent Implantation Failure, Granulocyte Colony-Stimulating Factor, Infertility","enrollment":100},{"nctId":"NCT03102606","phase":"PHASE3","title":"Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3","status":"COMPLETED","sponsor":"BeyondSpring Pharmaceuticals Inc.","startDate":"2018-05-29","conditions":"Chemotherapy-induced Neutropenia","enrollment":105},{"nctId":"NCT04651439","phase":"PHASE2, PHASE3","title":"Severe Bullous Drug Eruption and Filgrastim","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2022-05-13","conditions":"Rare Diseases, Toxic Epidermal Necrolyses","enrollment":42},{"nctId":"NCT05653713","phase":"PHASE1","title":"Effects of CSL324 in the Lung After Segmental Challenge","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2022-12-20","conditions":"Healthy Volunteers","enrollment":40},{"nctId":"NCT03640754","phase":"PHASE1","title":"A Study of the Safety and Effect of Repeated Administration of G-CSF on Hot Flashes in Postmenopausal Women","status":"COMPLETED","sponsor":"MenoGeniX, Inc.","startDate":"2018-08-06","conditions":"Postmenopausal Symptoms","enrollment":61},{"nctId":"NCT03197935","phase":"PHASE3","title":"A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2017-07-24","conditions":"Triple-negative Breast Cancer","enrollment":333},{"nctId":"NCT04211259","phase":"EARLY_PHASE1","title":"Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization","status":"UNKNOWN","sponsor":"Rutgers, The State University of New Jersey","startDate":"2022-04-18","conditions":"Plasma Cell Myeloma","enrollment":70},{"nctId":"NCT00046930","phase":"PHASE3","title":"Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2002-09-17","conditions":"Leukemia, Myelodysplastic Syndromes","enrollment":449},{"nctId":"NCT05881382","phase":"PHASE3","title":"Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction","status":"UNKNOWN","sponsor":"Recardio, Inc.","startDate":"2023-09","conditions":"ST Elevation Myocardial Infarction","enrollment":4100},{"nctId":"NCT04570267","phase":"PHASE1","title":"Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2020-10-08","conditions":"Healthy","enrollment":32},{"nctId":"NCT00650143","phase":"PHASE2, PHASE3","title":"Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2008-03","conditions":"Acute Myocardial Infarction","enrollment":174},{"nctId":"NCT02442180","phase":"PHASE3","title":"Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Steroid","status":"TERMINATED","sponsor":"Chuncheon Sacred Heart Hospital","startDate":"2015-07","conditions":"Alcoholic Hepatitis","enrollment":64},{"nctId":"NCT02149277","phase":"PHASE3","title":"Gcsf Injection in Women With Repeated Implantaiton Failure","status":"TERMINATED","sponsor":"Clinique Ovo","startDate":"2013-03","conditions":"Repeated Embryo Implantation Failure","enrollment":15},{"nctId":"NCT02502747","phase":"PHASE2","title":"RIGENERA 2.0 Trial","status":"WITHDRAWN","sponsor":"Catholic University of the Sacred Heart","startDate":"2020-01","conditions":"Anterior Myocardial Infarction, Heart Failure","enrollment":""},{"nctId":"NCT02093455","phase":"NA","title":"Effects of Chardonnay Seed Flour on Vascular Health","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2014-03","conditions":"1. Endothelial Dysfunction (EndoPAT Score <=2)","enrollment":168},{"nctId":"NCT02783937","phase":"PHASE4","title":"Filgrastim for Premature Ovarian Insufficiency","status":"COMPLETED","sponsor":"South Valley University","startDate":"2016-11","conditions":"Premature Ovarian Failure","enrollment":10},{"nctId":"NCT03486080","phase":"PHASE2","title":"Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction","status":"COMPLETED","sponsor":"Recardio, Inc.","startDate":"2018-12-07","conditions":"Acute Myocardial Infarction, Acute Myocardial Ischemia, STEMI - ST Elevation Myocardial Infarction","enrollment":49},{"nctId":"NCT03250338","phase":"PHASE3","title":"Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML","status":"UNKNOWN","sponsor":"Arog Pharmaceuticals, Inc.","startDate":"2018-06-05","conditions":"Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations","enrollment":322},{"nctId":"NCT00300053","phase":"PHASE2","title":"ACT34-CMI -- Adult Autologous CD34+ Cells","status":"COMPLETED","sponsor":"Lisata Therapeutics, Inc.","startDate":"2006-04","conditions":"Myocardial Ischemia","enrollment":321},{"nctId":"NCT03294577","phase":"PHASE3","title":"Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia","status":"UNKNOWN","sponsor":"BeyondSpring Pharmaceuticals Inc.","startDate":"2019-10-23","conditions":"Chemotherapy-induced Neutropenia","enrollment":221},{"nctId":"NCT03883386","phase":"PHASE2","title":"Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use","status":"TERMINATED","sponsor":"University of Michigan","startDate":"2019-06-24","conditions":"Bone Pain","enrollment":3},{"nctId":"NCT04519424","phase":"PHASE2","title":"CSL324 in COVID-19","status":"WITHDRAWN","sponsor":"CSL Behring","startDate":"2020-09","conditions":"Coronavirus Disease 2019 (COVID-19)","enrollment":""},{"nctId":"NCT01012297","phase":"PHASE3","title":"Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-11","conditions":"Recurrent Uterine Corpus Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma","enrollment":107},{"nctId":"NCT02154269","phase":"PHASE2","title":"Evaluation of G-CSF (Colony Stimulating Factor) in Patients With Chronic Chagas Cardiomyopathy","status":"COMPLETED","sponsor":"Hospital Sao Rafael","startDate":"2015-09","conditions":"Chronic Chagasic Myocarditis","enrollment":70},{"nctId":"NCT02215200","phase":"PHASE2","title":"ATG-GCSF in New Onset Type 1 Diabetes","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2014-12","conditions":"Diabetes Mellitus, Type 1","enrollment":89},{"nctId":"NCT03911037","phase":"PHASE2, PHASE3","title":"GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-05-04","conditions":"Decompensated Cirrhosis of Liver","enrollment":70},{"nctId":"NCT02392039","phase":"EARLY_PHASE1","title":"Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Lymphoma","enrollment":1},{"nctId":"NCT01508910","phase":"PHASE3","title":"Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina","status":"COMPLETED","sponsor":"Lisata Therapeutics, Inc.","startDate":"2012-04","conditions":"Chronic Myocardial Ischemia, Refractory Angina Pectoris, Advanced Coronary Heart Disease","enrollment":291},{"nctId":"NCT00545610","phase":"","title":"ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)","status":"COMPLETED","sponsor":"Lisata Therapeutics, Inc.","startDate":"2007-10","conditions":"Myocardial Ischemia","enrollment":150},{"nctId":"NCT00169104","phase":"PHASE2, PHASE3","title":"Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function","status":"TERMINATED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2002-07","conditions":"Metastatic Breast Cancer","enrollment":23},{"nctId":"NCT03407430","phase":"PHASE2","title":"Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain","status":"TERMINATED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2016-01-27","conditions":"Breast Cancer, Lymphoma, Pain","enrollment":11},{"nctId":"NCT03549728","phase":"PHASE2","title":"Effect of Granulocyte Colony-stimulating Factor on Clinical Pregnancy Rate in Patients With Endometriosis","status":"UNKNOWN","sponsor":"Amira Magdi Guergues Selim","startDate":"2018-06","conditions":"Recurrent Implantation Failure, Endometriosis","enrollment":88},{"nctId":"NCT02703051","phase":"PHASE1","title":"A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects","status":"COMPLETED","sponsor":"GlycoMimetics Incorporated","startDate":"2015-11","conditions":"Healthy Volunteers","enrollment":54},{"nctId":"NCT01820208","phase":"NA","title":"Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2014-03-01","conditions":"Severe Alcoholic Hepatitis","enrollment":28},{"nctId":"NCT03163862","phase":"PHASE2, PHASE3","title":"G-CSF Administration in IVF in a Preferable Preceptive Endometrium Score","status":"UNKNOWN","sponsor":"Istishari Arab Hospital","startDate":"2017-08-01","conditions":"Women Infertility","enrollment":100},{"nctId":"NCT01629537","phase":"PHASE2","title":"A Randomized, Placebo-Controlled Trial of Stellate Ganglion Block in the Treatment of Post Traumatic Stress Disorder","status":"COMPLETED","sponsor":"United States Naval Medical Center, San Diego","startDate":"2011-06","conditions":"Post Traumatic Stress Disorder (PTSD)","enrollment":41},{"nctId":"NCT02983708","phase":"PHASE1, PHASE2","title":"Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells","status":"COMPLETED","sponsor":"Hanyang University Seoul Hospital","startDate":"2011-08","conditions":"Neurodegeneration, G-CSF, Peripheral Blood Mononuclear Cells","enrollment":57},{"nctId":"NCT01383460","phase":"PHASE3","title":"Efficacy of Granulocyte Colony-stimulating Factor and Erythropoetin for Patients With Acute-on-chronic Liver Failure","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2011-07","conditions":"Acute on Chronic Hepatic Failure","enrollment":55},{"nctId":"NCT02104830","phase":"PHASE3","title":"Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients","status":"COMPLETED","sponsor":"Biocad","startDate":"2013-09","conditions":"Chemotherapy-induced Neutropenia","enrollment":135},{"nctId":"NCT02915796","phase":"PHASE1","title":"Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty","status":"UNKNOWN","sponsor":"Shanghai 10th People's Hospital","startDate":"2016-09","conditions":"Peripheral Arterial Disease","enrollment":345},{"nctId":"NCT02866331","phase":"PHASE2","title":"G-CSF and Autologous Cord Blood Infusion in Cerebral Palsy","status":"UNKNOWN","sponsor":"Hanyang University Seoul Hospital","startDate":"2016-07","conditions":"Cerebral Palsy","enrollment":88},{"nctId":"NCT02087176","phase":"PHASE2","title":"A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2014-03","conditions":"Previously Treated Non Small Cell Lung Cancer","enrollment":48},{"nctId":"NCT01227681","phase":"PHASE2","title":"Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease","status":"TERMINATED","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2010-06","conditions":"Parkinson Disease","enrollment":4},{"nctId":"NCT00886509","phase":"NA","title":"Peg-Granulocyte-Colony Stimulating Factor (GCSF) for Coronary Collateral Growth in Coronary Artery Disease Patients","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2009-03","conditions":"Coronary Artery Disease","enrollment":50},{"nctId":"NCT01065298","phase":"","title":"Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus-2","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2009-11","conditions":"Type 2 Diabetes Mellitus","enrollment":30},{"nctId":"NCT00629018","phase":"PHASE2","title":"Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2006-05","conditions":"Dilated Cardiomyopathy","enrollment":110},{"nctId":"NCT00662519","phase":"PHASE1","title":"Neulasta in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Florida","startDate":"2008-04","conditions":"Type 1 Diabetes","enrollment":21},{"nctId":"NCT00797056","phase":"EARLY_PHASE1","title":"Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2008-04","conditions":"Peripheral Vascular Diseases","enrollment":32},{"nctId":"NCT00741780","phase":"","title":"Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2006-06","conditions":"Multiple Myeloma, Autologous Transplantation","enrollment":164},{"nctId":"NCT01951027","phase":"PHASE1","title":"Phase I Study GX-G3 in Healthy Subjects","status":"COMPLETED","sponsor":"Genexine, Inc.","startDate":"2013-09","conditions":"Healthy","enrollment":53},{"nctId":"NCT01767714","phase":"PHASE3","title":"Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-04","conditions":"Non-Hodgkin's Lymphoma","enrollment":100},{"nctId":"NCT00103662","phase":"PHASE3","title":"Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2005-01","conditions":"Multiple Myeloma","enrollment":302},{"nctId":"NCT00103610","phase":"PHASE3","title":"Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2005-01","conditions":"Lymphoma, Non-Hodgkin","enrollment":298},{"nctId":"NCT00665314","phase":"PHASE2","title":"Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2007-11","conditions":"Lymphoma, Non Hodgkin's Lymphoma, Hodgkin's Disease","enrollment":5},{"nctId":"NCT00741325","phase":"","title":"Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2006-06","conditions":"Non-Hodgkin's Lymphoma, Autologous Transplantation","enrollment":178},{"nctId":"NCT01037543","phase":"PHASE1","title":"Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2009-11","conditions":"Healthy","enrollment":84},{"nctId":"NCT01302171","phase":"PHASE2","title":"Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy","status":"COMPLETED","sponsor":"Barts & The London NHS Trust","startDate":"2010-08","conditions":"Dilated Cardiomyopathy","enrollment":60},{"nctId":"NCT01825551","phase":"PHASE2, PHASE3","title":"The Effect of GCSF in the Treatment of ALS Patients","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-11","conditions":"Amyotrophic Lateral Sclerosis","enrollment":40},{"nctId":"NCT00747708","phase":"PHASE2, PHASE3","title":"Bone Marrow Derived Adult Stem Cells for Chronic Heart Failure","status":"COMPLETED","sponsor":"Barts & The London NHS Trust","startDate":"2005-08","conditions":"Chronic Ischaemic Heart Failure","enrollment":148},{"nctId":"NCT01384565","phase":"PHASE3","title":"G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver Disease","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2011-07","conditions":"Chronic Liver Disease","enrollment":55},{"nctId":"NCT00004132","phase":"PHASE2","title":"Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2000-01","conditions":"Drug/Agent Toxicity by Tissue/Organ, Leukemia, Lymphoma","enrollment":""},{"nctId":"NCT00004061","phase":"PHASE2","title":"Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1999-05","conditions":"Leukemia, Lymphoma, Oral Complications","enrollment":111},{"nctId":"NCT01311336","phase":"PHASE2","title":"Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain","status":"UNKNOWN","sponsor":"University of Vermont","startDate":"2011-05","conditions":"Pegfilgrastim-induced Back and Leg Pain","enrollment":55},{"nctId":"NCT01617577","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Filgrastim in Alzheimer's Disease","status":"COMPLETED","sponsor":"University of South Florida","startDate":"2009-06","conditions":"Alzheimer's Disease","enrollment":8},{"nctId":"NCT01560195","phase":"PHASE3","title":"A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2012-04","conditions":"NSCLC, Neutropenia, Febrile Neutropenia","enrollment":150},{"nctId":"NCT01713309","phase":"PHASE2, PHASE3","title":"Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim)","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"1996-01","conditions":"Acute Respiratory Failure, Critically Ill","enrollment":59},{"nctId":"NCT00476294","phase":"","title":"Long-Term Follow Up Study for AMD3100 Patients","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-10","conditions":"Myeloma","enrollment":7},{"nctId":"NCT00927836","phase":"PHASE2","title":"AXIS 2: AX200 for the Treatment of Ischemic Stroke","status":"COMPLETED","sponsor":"Sygnis Bioscience GmbH & Co KG","startDate":"2009-05","conditions":"Acute Ischemic Stroke","enrollment":328},{"nctId":"NCT01441427","phase":"PHASE1, PHASE2","title":"Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2010-01","conditions":"Feeding Intolerance, Necrotizing Enterocolitis","enrollment":93},{"nctId":"NCT00969826","phase":"PHASE1","title":"Pharmacokinetics and Pharmacodynamics of a Novel Pegylated Recombinant Human Granulocyte-Colony Stimulating Factor","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2008-09","conditions":"Healthy","enrollment":38},{"nctId":"NCT01036932","phase":"NA","title":"Granulocyte Colony Stimulating Factor(G-CSF) Therapy for Patients With ACLF","status":"UNKNOWN","sponsor":"Govind Ballabh Pant Hospital","startDate":"2008-12","conditions":"Acute on Chronic Liver Failure","enrollment":50},{"nctId":"NCT00772122","phase":"PHASE4","title":"Use of G-CSF for the Treatment of Unexplained Recurrent Miscarriage","status":"COMPLETED","sponsor":"University of Florence","startDate":"2000-01","conditions":"Habitual Abortion","enrollment":68},{"nctId":"NCT00756756","phase":"NA","title":"The Effect of Granulocyte Colony Stimulating Factor (G-CSF) on Myocardial Function After Acute Anterior Myocardial Infarction, a Prospective Double Blind Randomized Placebo Controlled Study","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2007-06","conditions":"Myocardial Infarction","enrollment":20},{"nctId":"NCT00213759","phase":"PHASE3","title":"Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF","status":"COMPLETED","sponsor":"University Hospital, Strasbourg, France","startDate":"2002-03","conditions":"Neutropenia in Prematures","enrollment":200},{"nctId":"NCT00126100","phase":"PHASE4","title":"Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)","status":"COMPLETED","sponsor":"Deutsches Herzzentrum Muenchen","startDate":"2004-02","conditions":"Myocardial Infarction","enrollment":114},{"nctId":"NCT00207792","phase":"PHASE3","title":"Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation","status":"UNKNOWN","sponsor":"Centre National de Greffe de Moelle Osseuse","startDate":"2005-07","conditions":"Graft vs Host Disease","enrollment":160},{"nctId":"NCT00542529","phase":"PHASE1, PHASE2","title":"Phase I/II, Randomized, Double-Blind, Study of the Progenitor Cell Mobilizing Effects of Imprime PGG™ Injection Administered at Varied Dosing Regimens With G-CSF Versus G-CSF Alone","status":"COMPLETED","sponsor":"HiberCell, Inc.","startDate":"2006-11","conditions":"Healthy","enrollment":66}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo+G-CSF","genericName":"Placebo+G-CSF","companyName":"Guangzhou Gloria Biosciences Co., Ltd.","companyId":"guangzhou-gloria-biosciences-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo+G-CSF, also known as filgrastim, is a protein-based treatment used in clinical trials for various conditions, including leukemia, lymphoma, oral complications, decompensated cirrhosis of the liver, and non-small cell lung cancer. It is administered as part of a treatment regimen that may include other interventions such as cyclophosphamide and palifermin.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}